Trademark: 79382573
Word
SEFILBI
Status
Pending
Status Code
686
Status Date
Tuesday, February 27, 2024
Serial Number
79382573
Mark Type
4000
Filing Date
Tuesday, October 3, 2023
Published for Opposition
Tuesday, February 27, 2024

Trademark Owner History
NOVARTIS AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 27, 2024
Published For Opposition
Feb 14, 2024
Notification Of Possible Opposition Sent To Ib
Feb 14, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 7, 2024
Notification Of Notice Of Publication E-Mailed
Feb 7, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2024
Approved For Pub - Principal Register
Jan 18, 2024
Assigned To Examiner
Jan 2, 2024
Teas Change Of Correspondence Received
Jan 2, 2024
Teas Change Of Domestic Representatives Address
Jan 2, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 2, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 2, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 2, 2024
Teas Change Of Owner Address Received
Nov 11, 2023
Application Filing Receipt Mailed
Nov 7, 2023
New Application Office Supplied Data Entered
Nov 6, 2023
Limitation From Original Application Entered
Nov 2, 2023
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24